1.20
price up icon3.45%   0.04
 
loading
前日終値:
$1.16
開ける:
$1.12
24時間の取引高:
1.93M
Relative Volume:
1.19
時価総額:
$272.76M
収益:
-
当期純損益:
$-179.82M
株価収益率:
-0.9023
EPS:
-1.33
ネットキャッシュフロー:
$-159.16M
1週間 パフォーマンス:
+15.38%
1か月 パフォーマンス:
+34.11%
6か月 パフォーマンス:
+72.51%
1年 パフォーマンス:
+88.44%
1日の値動き範囲:
Value
$1.12
$1.21
1週間の範囲:
Value
$1.03
$1.23
52週間の値動き範囲:
Value
$0.4993
$1.55

Gossamer Bio Inc Stock (GOSS) Company Profile

Name
名前
Gossamer Bio Inc
Name
セクター
Healthcare (1173)
Name
電話
(858) 684-1300
Name
住所
3115 MERRYFIELD ROW, SAN DIEGO, CA
Name
職員
145
Name
Twitter
@GossamerBio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
GOSS's Discussions on Twitter

GOSS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GOSS
Gossamer Bio Inc
1.20 236.39M 0 -179.82M -159.16M -1.33
Biotechnology icon
ONC
Beigene Ltd Adr
241.43 27.03B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.00 112.64B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 40.86M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.34 64.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.06 6.07B 0 -153.72M -103.81M -2.00

Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-25 開始されました Oppenheimer Outperform
2024-04-05 再開されました Wedbush Outperform
2023-07-27 ダウングレード UBS Buy → Neutral
2023-03-07 ダウングレード Raymond James Outperform → Mkt Perform
2023-03-01 開始されました Guggenheim Neutral
2022-12-07 ダウングレード Barclays Overweight → Equal Weight
2022-12-07 ダウングレード JP Morgan Neutral → Underweight
2022-12-07 ダウングレード SMBC Nikko Outperform → Neutral
2022-10-20 開始されました Goldman Buy
2022-09-21 開始されました JP Morgan Neutral
2022-09-19 開始されました Wedbush Outperform
2022-04-18 開始されました Raymond James Outperform
2022-04-06 開始されました UBS Buy
2022-01-10 アップグレード SMBC Nikko Neutral → Outperform
2021-11-09 再開されました Cantor Fitzgerald Overweight
2021-09-21 再開されました Piper Sandler Overweight
2020-06-29 開始されました H.C. Wainwright Buy
2020-04-22 開始されました Piper Sandler Overweight
2020-02-27 開始されました Barclays Overweight
2019-12-03 再開されました BofA/Merrill Buy
2019-10-30 開始されました Berenberg Buy
2019-03-05 開始されました Barclays Overweight
2019-03-05 開始されました BofA/Merrill Buy
2019-03-05 開始されました Evercore ISI Outperform
2019-03-05 開始されました SVB Leerink Outperform
すべてを表示

Gossamer Bio Inc (GOSS) 最新ニュース

pulisher
May 22, 2025

Cantor Fitzgerald Forecasts Gossamer Bio FY2025 Earnings - Defense World

May 22, 2025
pulisher
May 20, 2025

Analyze Gossamer Bio Inc (NASDAQ: GOSS) Before Investing. - Stocksregister

May 20, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

May 19, 2025
pulisher
May 18, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025
pulisher
May 18, 2025

Wedbush Reiterates “Outperform” Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

May 18, 2025
pulisher
May 18, 2025

The Goldman Sachs Group Raises Gossamer Bio (NASDAQ:GOSS) Price Target to $8.00 - Defense World

May 18, 2025
pulisher
May 17, 2025

GOSS Stock Update: Analyst Reiterates Outperform Rating | GOSS S - GuruFocus

May 17, 2025
pulisher
May 16, 2025

Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio (GOSS): Goldman Sachs Raises Price Target to $8.00 - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock - Investing.com

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ... - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strate - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Transcript : Gossamer Bio, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio earnings beat by $0.03, revenue topped estimates - Investing.com

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings: EPS Loss of $0.16 Beats Estimate, Revenue Surges to $9.9 Million - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GOSSAMER BIO Earnings Results: $GOSS Reports Quarterly Earnings - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key St - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key Studies | GOSS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study - Eagle-Tribune

May 15, 2025
pulisher
May 15, 2025

Gossamer Bio Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025
pulisher
May 14, 2025

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings - GuruFocus

May 14, 2025
pulisher
May 12, 2025

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025 - Eagle-Tribune

May 12, 2025
pulisher
May 08, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 7, 2025 - BioSpace

May 08, 2025
pulisher
May 07, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference - The Joplin Globe

May 07, 2025
pulisher
May 07, 2025

Market Highlights: Gossamer Bio Inc (GOSS) Ends on a Low Note at 1.09 - DWinneX

May 07, 2025
pulisher
May 05, 2025

Gossamer Bio Inc: Is GOSS Stock Worth Buying? - Stocksregister

May 05, 2025
pulisher
May 04, 2025

Gossamer Bio (GOSS) Expected to Announce Earnings on Tuesday - Defense World

May 04, 2025
pulisher
May 02, 2025

Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha

May 02, 2025
pulisher
May 01, 2025

Selling Buzz: Gossamer Bio Inc [GOSS] Chief Medical Officer Aranda Richard sells 1,908 shares of the company - knoxdaily.com

May 01, 2025
pulisher
Apr 30, 2025

Check out these key findings about Gossamer Bio Inc (GOSS) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Has $2.04 Million Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Was Gossamer Bio Inc (GOSS)’s session last reading good? - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Gossamer Bio Inc (GOSS) Stock: A Year of Declines and Increases - investchronicle.com

Apr 29, 2025
pulisher
Apr 28, 2025

Closing Strong: Gossamer Bio Inc (GOSS) Ends at 1.17, Up 0.86 from Last Close - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Monitoring Gossamer Bio Inc (GOSS) after recent insider movements - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Gossamer Bio Inc (GOSS Stock: A Sea of Opportunity - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Gossamer Bio Insider Confidence Rewarded, Stock Hits US$203m Market Cap - simplywall.st

Apr 25, 2025
pulisher
Apr 25, 2025

3 Promising Penny Stocks With Market Caps Over $100M - simplywall.st

Apr 25, 2025
pulisher
Apr 24, 2025

Taking the lead: Gossamer Bio Inc (GOSS) - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Oppenheimer initates Gossamer Bio Inc (GOSS) rating to an Outperform - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

GOSS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Stock Performance Spotlight: Gossamer Bio Inc (GOSS) Ends the Day at 0.83, Up by 1.77 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock - Yahoo Finance

Apr 22, 2025
pulisher
Apr 19, 2025

The Goldman Sachs Group Has Lowered Expectations for Gossamer Bio (NASDAQ:GOSS) Stock Price - Defense World

Apr 19, 2025

Gossamer Bio Inc (GOSS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
大文字化:     |  ボリューム (24 時間):